Rare diseases affect millions of families worldwide, often beginning before birth and continuing across a lifetime with complex medical needs. In recent years, gene therapy has opened new treatment pathways for conditions once considered untreatable.
This article surveys the companies and research centers leading gene therapy development for rare disease, and how patients can explore access.
